Clinicopathological features of superficial CD34-positive fibroblastic tumor

doi:10.12998/wjcc.v9.i12.2739

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5969)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

330

WORD

160

HTML

3311

Figures (1-4)

381

Tables (1-2)

291

Sum=4473

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

373

Download

1123

Sum=1496

Apr 26, 2021 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Apr 26, 2021; 9(12): 2739-2750
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2739

Full Size Figure Download Figure

Figure 4 ALK dual-color break-apart rearrangement probe detection by fluorescence in situ hybridization. All tested cases were negative for the inflammatory myofibroblastoma-associated ALK gene rearrangement.

Citation: Ding L, Xu WJ, Tao XY, Zhang L, Cai ZG. Clinicopathological features of superficial CD34-positive fibroblastic tumor. World J Clin Cases 2021; 9(12): 2739-2750
URL: https://www.wjgnet.com/2307-8960/full/v9/i12/2739.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i12.2739